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Chitinases hydrolyse the b(1,4)-glycosidic
bonds of chitin, an essential fungal cell wall
component. Genetic data on a subclass of fun-
gal family 18 chitinases have suggested a role
in cell wall morphology. Specific inhibitors of
these enzymes would be useful as tools to
study their role in cell wall morphogenesis and
could possess antifungal properties. Here, we
describe the crystallographic structure of a
fungal ‘‘plant-type’’ family 18 chitinase, that of
Saccharomyces cerevisiae CTS1. The enzyme
is active against 4-methylumbelliferyl chitooli-
gosaccharides and displays an unusually low
pHoptimum for activity. A library screen against
ScCTS1 yielded hits with Ki’s as low as 3.2 mM.
Crystal structures of ScCTS1 in complex with
inhibitors from three series reveal striking
mimicry of carbohydrate substrate by small
aromatic moieties and a pocket that could
be further exploited in optimization of these
inhibitors.
INTRODUCTION
Chitin is a tough, rigid, protective, linear polymer of b(1,4)-
N-acetyl-D-glucosamine (GlcNAc) and is a component of
arthropod exoskeletons and the cell walls of fungi. In these
organisms a dynamic balance between chitin synthesis
(through chitin synthases) and chitin hydrolysis (through
chitinases) is required to allow for growth and morphogen-
esis [1]. Chitinases, the enzymes that catalyze the hydroly-
sis of the b(1,4)-glycosidic bonds between GlcNAc mono-
mers, belong to CAZY (http://afmb.cnrs-mrs.fr/CAZY) [2]
glycoside hydrolase family 18 or 19. Fungi belonging to
the phylum Ascomycota possess several family 18 chiti-
nases belonging to two subclasses—some of these en-
zymes are similar to the well-characterized plant chitinase
hevamine from Hevea brasiliensis [3–5] (the ‘‘plant-type’’
family 18 chitinases), whereas others are similar to the
chitinases first characterized in bacteria (‘‘bacterial-type’’
family 18 chitinases) [6]. For instance, Saccharomyces
cerevisiae possesses two chitinase-encoding genes: theChemistry & Biology 14,plant-type chitinase ScCTS1 [7] with an apparent molecu-
lar weight of 130 kDa (including glycosylation) showing se-
quence similarity to hevamine; and ScCTS2 [8], which is
more similar to bacterial chitinases like chitinase A and B
from Serratia marcescens [6]. The genomes of the fungal
pathogens Aspergillus fumigatus and Candida albicans
contain many chitinases, with the former containing 14 chi-
tinases (of which 5 are of the plant-type [9]) and the latter 4
(of which 3 are of the plant-type [10]).
The bacterial-type chitinases have been extensively
studied. These enzymes are generally believed to show
mainly exo-activity, i.e., removing short chitooligosac-
charides from the end of long chitin chains [6]. Structures
for several of these enzymes, including chitinases A and B
from S. marcescens [11, 12] and several fungal chitinases
[13, 14] and mammalian chitinases [15], have been re-
ported, revealing a conserved catalytic core with several
exposed aromatic residues that are important for sub-
strate binding (Figure 1). Gene disruption studies of the
bacterial-type chitinase genes in A. fumigatus and Cocci-
dioides immitis have not revealed any significant pheno-
type, and it has been suggested that this subclass of
family 18 chitinases plays a role in metabolizing short
exogenous chitooligosaccharides [16, 17]. In contrast, ob-
servable phenotypes have been reported for the disrup-
tion of plant-type chitinases in fungi. A knockout of the
cts1 gene in S. cerevisiae resulted in a ‘‘clumping’’ pheno-
type, where, after cell division, mother and daughter cells
were unable to separate [18]. Treatment of S. cerevisiae
with a derivative of allosamidin (a well-characterized chiti-
nase inhibitor [19]) gave a remarkably similar phenotype
[20]. Furthermore, disruption of the chiA gene in A. nidu-
lans resulted in reduced germination and hyphal growth
[21]. Deletion of chitinase 3 from C. albicans generated
elongated chains of unseparated cells in the yeast growth
phase, resembling the phenotype of S. cerevisiae cts1
knockouts [10].
Despite the key role these plant-type chitinases appear
to play in fungal cell wall morphology and biogenesis, they
have not been extensively characterized. ScCTS1 is di-
vided into four domains [18]: a signal sequence (amino
acids 1–20), a catalytic domain (amino acids 21–315),
a Ser/Thr-rich domain (amino acids 315–480), and a
high-affinity chitin-binding domain (amino acids 481–
562). This domain organization is similar to most of the
plant-type chitinases in A. fumigatus and C. albicans589–599, May 2007 ª2007 Elsevier Ltd All rights reserved 589
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Structure of Saccharomyces cerevisiae Chitinase 1Figure 1. Overall Structure of ScCTS1 and Comparison to Other Family 18 Chitinases
Native ScCTS1 structure compared to the hevamine-allosamidin (PDB code 1LLO [23]) and AfChiB-allosamidin (PDB code 2A3E [14]) complexes.
The Glu157 and Asp155 from the family 18 chitinase DxE motif are shown with cyan carbon atoms (the equivalent residues in hevamine and AfChiB
are shown with the same colors). The three disulphide bridges in ScCTS1 and hevamine are represented in yellow. Solvent-exposed aromatic
residues are shown with green carbon atoms. Allosamidin is shown with magenta carbon atoms.[9, 10]. The chitin-binding domain of ScCTS1 may have
a role in localizing the enzyme to the cell wall [18]. Perhaps
due to their size, domain organization, or membrane local-
ization, only a few plant-type fungal chitinases have so far
been successfully overproduced in recombinant form
(e.g., [22]). However, hevamine, the plant chitinase from
H. brasiliensis, has been characterized in some detail. Hev-
amine has been shown to be an endo-chitinase [3, 5] with
a catalytic core distantly similar to those of the bacterial-
type chitinases, but possessing a more exposed sub-
strate-binding groove. Structural work on hevamine in
conjunction with inhibitor studies was instrumental in
showing that this enzyme, and indeed all family 18 chiti-
nases, proceed through a ‘‘substrate-assisted’’ reaction
mechanism where theN-acetyl moiety of the sugar toward
the nonreducing end of the glycosidic bondacts as anucle-
ophile, forming an oxazolinium ion intermediate [3, 23, 24].
The potent chitinase inhibitor allosamidin, a pseudo-
trisaccharide [19, 25], accurately mimics this reaction
intermediate, as elegantly shown through X-ray crystallo-
graphic studies [23], and inhibits most chitinases from
the GH 18 family. Mutagenesis studies on hevamine have590 Chemistry & Biology 14, 589–599, May 2007 ª2007 Elsevierconfirmed the role of the two acids in the conserved GH
18 DxE motif, with the glutamate being the catalytic acid
protonating the glycosidic bond, and the aspartate playing
a key role in assisting the acetamido group in its nucleo-
philic attack and stabilizing the developing positive charge
on the oxazolinium ion [5, 24].
Despite the considerable amount of genetic data on the
fungal plant-type chitinases, their precise roles are still un-
clear. This is largely due to the presence of many of these
genes in the fungal genomes and the shortcomings of the
genetic approach in terms of generating multiple-gene
knockouts to overcome the effects of redundancy. Given
the relatively large degree of sequence conservation of
these enzymes, it is possible that a potent, specific,
small-molecule inhibitor could be developed that would
inhibit all plant-type chitinases, allowing the phenotype
of a total knockdown of these enzymes to be studied. Fur-
thermore, such a molecule could be a lead for the devel-
opment of a chitinase inhibitor with antifungal properties.
Here, we have taken a first step in this direction by
developing an overexpression system for ScCTS1 and
determining its structure by X-ray crystallography. ALtd All rights reserved
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Structure of Saccharomyces cerevisiae Chitinase 1Table 1. Details of Data Collection and Structure Refinement
Native 8-Chlorotheophylline Kinetin Acetazolamide
Unit cell (A˚) a = 73.63 a = 73.41 a = 73.34 a = 73.44
b = 112.83 b = 112.71 b = 111.62 b = 113.51
c = 37.35 c = 37.33 c = 37.26 c = 37.49
Resolution (A˚) 20–1.60 (1.66–1.60) 20–1.90 (1.97–1.90) 20–1.60 (1.66–1.60) 20–1.75 (1.81–1.75)
# Observed reflections 135,336 (11,786) 84,124 (8,133) 141,115 (9,208) 122,213 (11,354)
# Unique reflections 39,503 (3,745) 24,548 (2,419) 39,904 (3,162) 30,667 (3,049)
Redundancy 3.4 (3.1) 3.4 (3.4) 3.5 (2.9) 4.0 (3.7)
I/sI 14.9 (3.3) 9.0 (3.0) 9.7 (2.3) 9.4 (2.4)
Completeness 94.2 (90.8) 98.3 (98.8) 96.8 (78.1) 95.4 (96.9)
Rmerge 0.036 (0.285) 0.081 (0.434) 0.078 (0.390) 0.072 (0.433)
R, Rfree 0.166, 0.192 0.198, 0.258 0.193, 0.222 0.183, 0.232
Rmsd from ideal geometry
Bonds (A˚) 0.014 0.016 0.014 0.014
Angles () 1.4 1.5 1.5 1.5
B factor rmsd (A˚2) (backbone bonds) 0.83 0.86 0.81 0.83
<B > (A˚2)
Protein 20.1 12.9 27.1 33.2
Ligand 36.9 9.1 19.0 36.8
Water 28.5 18.0 29.7 33.7
Values in parentheses are for the highest resolution shell. All measured data were included in structure refinement. All crystals were
of space group P21212.high-throughput screen based on a fluorescent enzyme
assay was then used to identify three inhibitor scaffolds.
The most potent of these, kinetin (Ki = 3.2mM), is a compet-
itive inhibitor of the enzyme that occupies a deep pocket.
Site-directed mutagenesis was used to reveal the impor-
tance of this pocket in determining inhibitor potency.
This work provides a solid basis for the development of
a plant-type fungal chitinase inhibitor.
RESULTS AND DISCUSSION
ScCTS1 Contains a Substrate-Binding Groove
Compatible with Endo Activity
Characterization of the activity and structure of the ‘‘plant-
type’’ fungal chitinases has been hampered by difficulties
in overexpressing recombinant forms of these enzymes.
We have expressed the catalytic domain of ScCTS1 (com-
prising of amino acids 22 to 315) as a secreted N-terminally
His-tagged fusion protein in Pichia pastoris, producing ap-
proximately 50 mg per liter of medium. Purification using
Ni-affinity chromatography and gel filtration yielded ap-
proximately 15 mg of pure protein per liter of media. The
protein was then crystallized from phosphate buffers, and
the structure was solved by molecular replacement and re-
fined against synchrotron diffraction data to 1.6 A˚ (Table 1).
The ScCTS1 structure represents the first example, to
our knowledge, of a plant-type fungal chitinase. The near-
est structural homolog is the plant chitinase hevamineChemistry & Biology 14,[3], which is 36% identical at the sequence level and super-
poses ontoScCTS1 with an rmsd of 1.6 A˚ on 256 Ca atoms
(Figure 1). The typical (b/a)8 TIM-barrel is structurally con-
served, as are the three disulphide bonds (Figure 1).
Although the active site residues and TIM-barrel fold are
conserved, there exist significant structural differences
between ScCTS1 and the bacterial-type fungal chitinase,
as evident from a comparison with the A. fumigatus chiti-
nase B1 (AfChiB1) structure [14] (Figure 1). Most notable is
the fact that, whereas ScCTS1 and hevamine contain
a minimal TIM-barrel fold similar to the structure of
TinyTIM [26], AfChiB1 contains a highly decorated TIM-
barrel with a large a/b domain inserted in one of the loops
and several other larger loops (Figure 1). The result of this
is that, whereas ScCTS1 and hevamine contain a shallow
substrate-binding groove, the bacterial-type chitinases
contain deep substrate-binding grooves, in some cases
even forming tunnels [11–15, 27]. There are further signif-
icant differences in the nature of the side chains lining the
substrate-binding grooves. Whereas a large path of highly
conserved aromatic residues involved in substrate bind-
ing lines the active-site grooves of the bacterial-type chi-
tinases [15, 27, 28], there is only one conserved solvent-
exposed tryptophan in ScCTS1 (Trp285) and hevamine
(Trp255) (Figure 1). This difference in substrate-binding
groove architecture correlates with the known endo-chiti-
nase activities of ScCTS1 [7] and hevamine [4] and the
mostly exo-acting bacterial-type chitinases [6].589–599, May 2007 ª2007 Elsevier Ltd All rights reserved 591
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Structure of Saccharomyces cerevisiae Chitinase 1Figure 2. Sequence Conservation in the Plant-Type Fungal Family 18 Chitinases
(A) Multiple sequence alignment between the catalytic cores of ScCTS1, CaCHT3, AnChiA, and hevamine. Green triangles represent the catalytic
glutamic acids, pink triangles identify active site residues, and yellow triangles represent amino acids in a plant-type family 18 chitinase specific
pocket.
(B) Stereo image of the nativeScCTS1 structure, with a molecular surface colored by sequence conservation following the alignment in (A) (magenta =
identical residue, pink = conserved residue, gray = unconserved residue). Allosamidin (thin lines) from the hevamine-allosamidin complex is
superposed into the ScCTS1 active site for reference. The 4 to +2 sugar-binding subsites following standard nomenclature are labeled. The arrow
indicates the pocket referred to in (A).The Plant-Type Fungal Chitinases Possess
a Conserved Active Site
Previous structural studies of hevamine in complex with
the inhibitor allosamidin [23] (Figures 1 and 2B) or sub-
strate fragments [3, 24] have defined the GlcNAc subsites
in the enzyme, which form a shallow groove on the surface
of the protein, also observed in the ScCTS1 structure
(Figure 2B). The groove consists of six sugar-binding sub-592 Chemistry & Biology 14, 589–599, May 2007 ª2007 Elseviesites, numbered from 4 (the nonreducing end) to +2 (the
reducing end), with hydrolysis taking place on the glyco-
sidic bond between the 1 and +1 subsites [3, 23, 24].
Subsites 4 and 3 are highly solvent exposed, and the
side chains forming these subsites are not well conserved
(Figures 2A and 2B). Subsites 2 to +2 form a deep
groove, lined by side chains that are highly conserved in
the plant-type family 18 chitinases (Figures 2A and 2B).r Ltd All rights reserved
Chemistry & Biology
Structure of Saccharomyces cerevisiae Chitinase 1Figure 3. Enzyme Activity and Inhibition
(A) pH-activity profile of kcat/Km at different concentrations of substrate (4MU-GlcNAc3) (from 0 to 800 mM) for ScCTS1.
(B) Chemical structures of allosamidin, 8-chlorotheophylline, acetazolamide, and kinetin.
(C) Lineweaver-Burk plots of kinetin measured against ScCTS1 at different concentrations of inhibitor. A fit of all the data against a competitive
inhibition model resulted in a Ki of 3.2 ± 0.3 mM, with a Vmax of 0.0066 ± 0.0015 mM/s and Km of 1000 ± 30 mM.In the 1 subsite, Asp155 and Glu157 in ScCTS1 (equiva-
lent to Asp125 and Glu127 in hevamine) at the end of b4
correspond to the residues in the family 18 chitinase
DxE motif (see CAZY [2]). Glu157 is the catalytic acid,
with Asp155 stabilizing the oxazolinium ring of the reaction
intermediate. Notably, a tryptophan that is completely
conserved in all family 18 chitinases (Trp285 in ScCTS1,
equivalent to Trp255 in hevamine) forms the bottom of
the 1 subsite, with a conserved tyrosine (Tyr214 in
ScCTS1, equivalent to Tyr183 in hevamine) forming one
of the sides. The 2 and 3 subsites are considerably
more exposed; nevertheless, most of the residues that
are seen to hydrogen bond the 2/3 sugars in the
hevamine-allosamidin complex are also conserved in
ScCTS1 [23] (Figure 2B). In theScCTS1 structure, a pocket
lined with conserved residues is observed next to the 1
subsite (Figures 2A and 2B).
Recombinant ScCTS1 Is Active against
4MU-Glycosides
The activities of ScCTS1 and hevamine on polymeric chi-
tin have been extensively studied, showing that these
enzymes are endo-chitinases [3, 5, 7]. To allow future
rapid evaluation of inhibitors, we decided to investigate
the activity of ScCTS1 on 4-methylumbelliferyl chitooligo-
saccharides. Steady-state kinetics of ScCTS1 was estab-
lished with 4MU-GlcNAc3, yielding a Km of 1 mM, with
a kcat of 1.3 s
1. While the turnover rate of the enzyme is
comparable to the steady kinetics reported for hevamine
on GlcNAc5, there exists a significant difference in the
Km (Km of 16 mM, with a kcat of 0.6 s
1 for hevamine [5]).
This difference is likely to be due to the degree of polymer-
ization of the substrate and the presence of the 4MU
group instead of a GlcNAc unit in the +1 subsite. Activity
against 4MU-GlcNAc2 was also tested, and although turn-
over could be detected this was not sufficient to establish
proper steady-state kinetics.Chemistry & Biology 14,Recombinant ScCTS1 Has an Unusual pH Optimum
Using the 4MU-GlcNAc3 substrate, the pH dependence of
ScCTS1 in the pH range 2.2–7.0 was investigated. The en-
zyme shows a significant increase in activity toward the
low pH range, with maximal kcat of 5.7 s
1 and kcat/Km
of 0.0052 s1mM1 at pH 2.6 (Figure 3A). The Km in the
pH 2.2–5.0 range was between 1.0 and 1.4 mM, while at
pH 6 and 7 the Km was 3.0 and 2.8 mM, respectively.
This is similar to what has been described for native
ScCTS1 partially purified from yeast extracts [7] and hev-
amine [5]. Such an unusual pH optimum has not been ob-
served for the bacterial-type chitinases, which generally
possess pH optima around pH 5–6 [6], with one notable
exception. The acid mammalian chitinase (AMCase),
which falls within the bacterial-type chitinase subclass,
also displays a pH optimum of around 2–3 [29]. Recent
structural analysis of human AMCase has revealed that
this shift in pH optimum is due to the mutation of a basic
residue adjacent to a conserved aspartic acid positioned
near the substrate in the 1 subsite of the active site
(O.A. Andersen and D.M.F.v.A., unpublished data). Inter-
estingly, in all plant-type family 18 chitinases this con-
served aspartic acid is changed to a conserved aspara-
gine (Asn215 in ScCTS1; Figure 2A). Mutation of the
aspartic acid to an alanine in the bacterial-type family 18
chitinase B from S. marcescens resulted in a significant
downward shift of the pH optimum [30]. It is tempting to
speculate that the asparagine at the equivalent position
in the plant-type fungal chitinases is the source of the
unusually low pH optimum.
ScCTS1 Is Inhibited by Allosamidin
and Purine Derivatives
Allosamidin is a potent inhibitor of both bacterial-type and
plant-type family 18 chitinases, and its mode of binding
has been extensively characterized through enzymology
and X-ray crystallography [13, 14, 23, 27, 31]. The hev-
amine-allosamidin complex has shown that the inhibitor589–599, May 2007 ª2007 Elsevier Ltd All rights reserved 593
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Structure of Saccharomyces cerevisiae Chitinase 1Figure 4. Comparison of Allosamidin
and Theophylline Binding to Family 18
Chitinases
(A and B) Comparison of hevamine in complex
with allosamidin (PDB entry 1LLO [23]), with a
model of ScCTS1 in complex with allosamidin,
obtained by superposition of the hevamine-
allosamidin complex (A), and comparison of
ScCTS1 in complex with 8-chlorotheophylline
and the previously determined AfChiB-theoph-
ylline complex [33] (B). Residues lining the ac-
tive site are shown as sticks with gray carbon
atoms. Inhibitors are shown as sticks with
magenta carbon atoms. Protein-inhibitor hy-
drogen bonds are shown as dotted green lines.
Unbiased (i.e., before inclusion of any inhibitor
model) jFoj  jFcj, fcalc electron density maps
are shown at 2.5s. In the allosamidin com-
plexes, the sugar subsites are labeled from
3 to 1. Water molecules involved in hydro-
gen bonds with the ligand or the protein are
shown as orange spheres.mimics the oxazolinium intermediate through hydrogen
bonds with the conserved Asp125 (Asp155 in ScCTS1)
and Tyr183 (Tyr214 in ScCTS1) and extensive stacking
with the conserved Trp255 (Trp285 in ScCTS1) [23] (Fig-
ure 4). A modeled ScCTS1-allosamidin complex shows
that the majority of the hydrogen bond interactions be-
tween the enzymes and the two sugars are conserved
(Figure 4A). Given the conservation of these residues
throughout the plant-type fungal chitinases, it is not sur-
prising that allosamidin has been reported to inhibit
partially purified ScCTS1 [20]. Similarly the ScCTS1 re-
combinant enzyme is competitively inhibited by allosami-
din (Ki = 0.61 ± 0.02 mM [Table 2]; the Ki against hevamine
has been reported to be 3.1 mM [4]). Allosamidin is not an
attractive starting point for the synthesis of potent plant-
type fungal chitinase inhibitors due to its inherent non-
drug-likeness (hydrophilic cLogP [5.2], high molecular
weight, and presence of glycosidic bonds) and its compli-
cated synthesis [32]. Recently, the more drug-like purine
theophylline and derivatives thereof were identified as
competitive bacterial-type family 18 chitinase inhibitors,
displaying up to 3 mM inhibition and extensive mimicry
of the allosamidin-chitinase interactions, as shown in
Figure 4B [33, 34]. We investigated the inhibitory potential
of these compounds against ScCTS1, revealing that the
theophylline derivative 8-chlorotheophylline inhibits the
enzyme with a Ki of 600 ± 64 mM (Table 2). This prompted
us to investigate the binding mode of this compound. The
crystal structure of ScCTS1 complexed with 8-chloro-
theophylline was determined to 1.9 A˚, with the final model
of the complex giving an R factor of 0.198 (Rfree = 0.258).
The inhibitor shows extensive p-p stacking with Trp285 in594 Chemistry & Biology 14, 589–599, May 2007 ª2007 Elseviethe bottom of the1 subsite, occupying the same position
as observed in theAfChiB-theophylline complex (Figure 4).
Furthermore, the same hydrogen bonds are observed,
from Tyr214 to the N9 nitrogen, from Asp155 to the N7 ni-
trogen, and from the backbone nitrogen of Ala110 to the
O6 oxygen of the inhibitor. Notably, the 8-chloro atom
points into the direction of the deep pocket that is ob-
served in the native ScCTS1 structure (Figure 2B)—this
pocket is absent in the structure of bacterial-type chiti-
nases such as AfChiB1 (Figure 4B). Strikingly, two water
molecules are occupying this pocket in the ScCTS1-8-
chlorotheophylline complex (Figure 4B). This suggests
that inhibitors possessing moieties that could occupy
this pocket and displace these water molecules would
give additional favorable entropic contributions to binding.
Table 2. Inhibition ofWild-TypeScCTS1, theAla283Ser
Mutant, and the Ala283Ser/Phe210Trp Double Mutant
by Allosamidin, Kinetin, Acetazolamide,
and 8-Chlorotheophylline
WT Ala283Ser
Ala283Ser/
Phe210Trp
Allosamidin 0.61 ± 0.02 0.66 ± 0.4 1.46 ± 0.03
Kinetin 3.2 ± 0.3 >5000 >5000
Acetazolamide 21 ± 2 71 ± 17 128 ± 11
8-Chlorotheophylline 600 ± 64 1155 ± 87 1192 ± 262
The values shown are Kis in mM, calculated from Lineweaver-
Burk analysis (for kinetin and acetazolamide against WT) or
from IC50 curves using the Cheng & Prusoff equation (all other
values). Errors represent standard deviation.r Ltd All rights reserved
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Structure of Saccharomyces cerevisiae Chitinase 1Figure 5. Binding the Kinetin and Acetazolamide Inhibitors to ScCTS1
The structures of the ScCTS1-kinetin and ScCTS1-acetazolamide complexes are shown. Residues lining the active site are shown as sticks with gray
carbon atoms. Inhibitors are shown as sticks with magenta carbon atoms. Protein-inhibitor hydrogen bonds are shown as dotted green lines.
Unbiased (i.e., before inclusion of any inhibitor model) jFoj  jFcj, fcalc electron density maps are shown at 2.5s. Water molecules involved in hydrogen
bonds with the ligand or the protein are shown as orange spheres.We next attempted to identify such inhibitors by a high-
throughput screening campaign using a library of drug
molecules.
Discovery of ScCTS1 Inhibitors Kinetin
and Acetazolamide
A library of 880 drug-like molecules (The Prestwick Chem-
ical Library) was screened at 40 mg/ml (approximately
equivalent to 80 mM, assuming a molecular weight of
500) using 100 mM of 4MU-GlcNAc3. This led to the iden-
tification of two structurally distinct inhibitors, kinetin (a
plant hormone) and acetazolamide (a well known carbonic
anhydrase inhibitor) (Figure 3B). We next investigated the
mode of inhibition of these compounds. Steady-state ki-
netics at different concentrations of 4MU-GlcNAc3 in the
presence of increasing amounts of the inhibitors showed
that kinetin (Ki = 3.2 mM; Figure 3C) and acetazolamide
(Ki = 21 mM) were both competitive inhibitors.
Next, the binding modes of these inhibitors were in-
vestigated by X-ray crystallographic analysis of theirChemistry & Biology 14, 5complexes with ScCTS1. The ScCTS1-acetazolamide
complex was refined against 1.75 A˚ synchrotron data,
yielding a final model with an R factor of 0.183 (Rfree =
0.232; Table 1). Despite containing a substantially differ-
ent aromatic heterocycle, acetazolamide binds in a sur-
prisingly similar mode as 8-chlorotheophylline (Figures
4B and 5). The stacking interaction with Trp285, and the
hydrogen bonds with Tyr214, Asp155, and the backbone
of Ala110 are conserved.
An additional hydrogen bond is observed between the
catalytic acid (Glu157) and the acetamido nitrogen (Fig-
ure 5). The sulfonamide group points toward the 2/3
subsites, making weak interactions with the Trp285 indole
nitrogen and an ordered water molecule. Notable, the
deep pocket present in the ScCTS1 structure is still occu-
pied by two ordered water molecules (Figure 5).
The structure of the ScCTS1-kinetin complex was re-
fined against 1.6 A˚ synchrotron data, yielding a final model
with an R factor of 0.193 (Rfree = 0.222; Table 1). Although
the purine substructure of kinetin binds in the same89–599, May 2007 ª2007 Elsevier Ltd All rights reserved 595
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Structure of Saccharomyces cerevisiae Chitinase 1position as 8-chlorotheophylline, it does so in a different
orientation (Figures 4 and 5). There is still extensive stack-
ing between the purine moiety and Trp285, and hydrogen
bonds to Tyr214 and Asp155 are also observed. The direct
hydrogen bond to the backbone nitrogen of Ala110 ob-
served in the 8-chlorotheophylline and acetazolamide
complexes is a water-mediated hydrogen bond in the ki-
netin complex (Figures 4 and 5). However, the main differ-
ence between the binding mode of kinetin and the other
previously characterized inhibitors is that the kinetin furan
group occupies the deep pocket, displacing the previously
observed ordered water molecules in the 8-chlorotheo-
phylline/acetazolamide complexes (Figures 4 and 5). Fur-
thermore, the furan group oxygen is also in a position suit-
able for stacking with the Tyr32 aromatic side chain. These
extra interactions of the furfuryl group are likely to be
the source of the tighter binding of the inhibitor, approach-
ing the inhibition by allosamidin to within an order of
magnitude.
A Key Amino Acid Regulates Plant-Type Fungal
Chitinase Inhibitor Sensitivity
The deep pocket in the ScCTS1 chitinase (Figures 2B, 4,
and 5) appears to be a key opportunity for increasing affin-
ity both through displacement of ordered water molecules
and establishment of further interactions. However, while
the catalytic machinery of the plant-type fungal chitinases
is fully conserved, analysis of sequence conservation
around this pocket reveals two positions of sequence var-
iation (Figure 2). Amino acid 283 is an alanine, situated at
the bottom of the ScCTS1 pocket (Figure 4). In hevamine,
however, this residue is a much larger methionine
(Met253; Figure 4A). A methionine is also observed in
A. nidulans chitinase A, whereas a serine is present at
the equivalent position in all C. albicans plant-type chiti-
nases (Figure 2). It is thus worth establishing the effect
of the presence of these larger side chains on the inhibi-
tory potential of the inhibitors studied here. The ScCTS1
mutant A283S was made, emulating the pocket as present
in the C. albicans plant-type chitinases. Steady-state
kinetics of this mutant showed a similar Km (0.8 versus
1 mM for wild-type) and turnover number kcat (2.3 versus
1.3 for wild-type) as for the wild-type enzyme. Strikingly,
while inhibition by allosamidin, acetazolamide, and 8-
chlorotheophylline (Table 2) appeared to not be signifi-
cantly affected by the larger serine present at position
283, inhibition by kinetin was no longer detectable. These
data indicate that while in the C. albicans plant-type chiti-
nases, which possess the large serine, a pocket may still
exist, it is no longer able to accommodate large groups
such as the kinetin furan side chain. It is likely that the me-
thionines observed at this position for both the A. nidulans
chitinase A and hevamine (Figure 2) would similarly abol-
ish inhibition by kinetin. Indeed, the presence of this me-
thionine in hevamine could be the source of the difference
in allosamidin inhibition of ScCTS1 (Ki = 0.61 mM) and hev-
amine (Ki = 3.1 mM).
The second position of sequence variation in the
pocket in ScCTS1 is Phe210, which is a tryptophan in596 Chemistry & Biology 14, 589–599, May 2007 ª2007 Elseviehevamine and A. nidulans ChiA (Figure 2). To probe the
effect of this sequence variation on the structure of the
pocket and binding of the inhibitors, the double mutant
Phe210Trp/Ala283Ser was studied. Steady-state kinetics
of this double mutant showed a similar Km (1.1 versus
1 mM for wild-type) and turnover number kcat (0.8 versus
1.3 for wild-type) as for the wild-type enzyme and the sin-
gle Ala283Ser mutant. Again, while inhibition by allosami-
din, acetazolamide, and 8-chlorotheophylline (Table 2)
did not appear to be significantly affected by the larger
Ser183 and Trp210, inhibition by kinetin was no longer
detectable. These results indicate that sequence varia-
tion at position 283 appears to be a key determinant for
binding affinities for inhibitors that occupy the deep
pocket.
Concluding Remarks
Since the first report of the cell-clumping phenotype ob-
served upon disruption of the cts1 gene [18] or inhibition
of the ScCTS1 chitinase activity with allosamidin [20], no
complete knockout of all fungal plant-type chitinases in
a single organism has been reported. Due to the large
amount of redundancy in the fungal chitinase genes, the
genetic approach toward knocking out all chitinase activ-
ity in a single fungal species is difficult to achieve. Because
of this lack of genetic data, it is still difficult to ascertain the
involvement of these plant-type fungal chitinases in
virulence, morphogenesis, or growth. The work described
here represents a first step toward the design and synthe-
sis of a chemical tool to give significant inhibition of this
subclass of family 18 chitinases. While the three scaffolds
identified do not currently give submicromolar inhibition
and the most potent of these, kinetin, appears sensitive
to the identity of an unconserved amino acid, they are
drug-like fragments that are synthetically accessible and
could be further optimized using the structural data pre-
sented here.
SIGNIFICANCE
Chitinases are enzymes that catalyze the hydrolysis of
the b(1,4)-glycosidic bonds between the N-acetyl-D-
glucosamine (GlcNAc) monomers of chitin. Within
the family 18 chitinases, two subfamilies exist, the ex-
tensively studied bacterial-type chitinases and the
less well-studied plant-type chitinases with as proto-
type hevamine from Hevea brasiliensis. Both classes
of enzymes are found in the genomes of yeast and
fungi. Whereas the bacterial-type family 18 chitinases
are nonessential, genetic data on the plant-type family
18 chitinases point to a role in cell wall morphology.
For example, disruption of Aspergillus nidulans chiA
leads to a defect in germination and hyphal growth,
whereas the Saccharomyces cerevisiae chitinase 1
(ScCTS1) plays a key role in separation of mother
and daughter cells at the end of cell division. Specific
inhibitors of these enzymeswould be useful as tools to
study their role in cell wall morphogenesis and could
possess antifungal properties. Here, we describe ther Ltd All rights reserved
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Structure of Saccharomyces cerevisiae Chitinase 1crystallographic structure of a fungal plant-type family
18 chitinase, that of ScCTS1 and the results from a
high-throughput screenagainstScCTS1usinga library
of currently marketed drugs, which could form the
basis for development of inhibitors specific for this
subclass of family 18 chitinases.
EXPERIMENTAL PROCEDURES
Materials
Oligonucleotides were supplied by the oligo synthesis service (School
of Life Sciences, University of Dundee, UK). Restriction enzymes were
obtained from New England Biolabs. Platinum high-fidelity Taq DNA
polymerase, pCR2.1TOPO, pPICZaA, and X-33 strain were from
Invitrogen. 4-methylumbelliferyl-b-D-N,N0,N00-triacetyl-chitotrioside
(4MU-GlcNAc3) was from Sigma-Aldrich. HiTrapTM chelating HP
column and glutathione sepharoseTM 4B were from Amersham Bio-
sciences. All plasmids were verified by the sequencing service (School
of Life Sciences, University of Dundee).
Cloning, Expression, and Purification
The cts1 gene from Saccharomyces cerevisiae was amplified using
Platinum Taq DNA polymerase (Invitrogen), genomic DNA (AY925),
and 50 and 30 end primers. The forward primer was 50-TCTTCTGGT
CTGGAAGTTCTGTTCCAAGGGCCACTGGATAGGTCTGCTAACAC
AAATATTGCTG-30, and the reverse primer was 50-CCGCGGTCAT
CAGGCGGTCTGGCTAGCACTTG-30. In the forward primer, the se-
quence encoding a PreScission cleavage site is shown in bold, and
in the reverse primer a SacII restriction site is shown in italics. The
PCR product was purified and used as a template for PCR using the
50 end primer 50CTCGAGAAAAGAGAGGCTGAAGCTCATCACCATC
ACCATCACTCTTCTGGTCTGAAGTTCTGTTCCAAGGGCCACTG-30.
In this primer, the sequence encoding a histidine tag is shown in bold,
and a XhoI restriction site is shown in italics. The PCR product was
ligated into a pCR2.1TOPO expression vector by the TOPO directional
cloning procedure (Invitrogen). This vector was double digested
with XhoI and SacII restriction enzymes, and the insert was ligated
into pPICZaA. The plasmids were isolated from E. coli DH5a strain
(pPICZaAsccts1). pPICZaAsccts1 was digested with SacI and trans-
formed into X-33 strain with the LiCl method (Invitrogen). Transform-
ants were selected on YPD plates (1% [w/v] yeast extract, 2% [w/v]
peptone, 2% [w/v] dextrose) containing 100 mg/ml of zeocin (Invitro-
gen). Batch cultures were performed in 100 ml volume of BMGY me-
dium (1% [w/v] yeast extract, 2% [w/v] peptone, 100 mM potassium
phosphate [pH 6.0], 1.34% [w/v] yeast nitrogen base, and 1% [v/v]
glycerol). 50 ml was utilized to grow 500 ml of BMGY medium overnight
at 30C, and expression was induced by methanol (1%, v/v) for 72 hr at
room temperature in a shaking incubator (270 rpm). Yeast cells were
harvested by centrifugation at 3480 3 g for 30 min.
The supernatant of the centrifugation containing soluble ScCTS1
was filtered, concentrated, and dialyzed three times against 5 liters
of buffer A (50 mM sodium phosphate, 300 mM sodium chloride,
and 10 mM imidazole [pH 8]) at 4C overnight, and applied onto a
HiTrap chelating HP column (5 ml) previously equilibrated with buffer
A at a flow rate of 1 ml/min. The protein was washed with buffer A
and eluted with buffer B (50 mM sodium phosphate, 300 mM sodium
chloride, and 300 mM imidazole [pH 8]). After concentrating and dialyz-
ing it against buffer C (50 mM HEPES, 250 mM sodium chloride, and
2 mM DTT [pH 7.5]), the protein was digested overnight with GST-
PreScission protease at 4C. The GST-PreScission protease was
removed with glutathione sepharose 4B, and ScCTS1 was then ap-
plied onto a gel filtration column previously equilibrated with buffer
C. Protein was concentrated and analyzed by SDS-PAGE followed
by Coomassie blue staining. The purified ScCTS1 protein was used
for kinetic analyses and crystallization trials. Construction of the
ScCTS1 mutants was done by mutagenesis using the QuikChange
Site-Directed Mutagenesis Kit, following the manufacturer’s instruc-Chemistry & Biology 14, 5tions. The mutant proteins were purified using the same procedures
as used for the wild-type enzyme.
Enzymology
Michaelis-Menten parameters of ScCTS1 were determined using the
fluorogenic substrate 4MU-GlcNAc3. Standard reaction mixtures con-
tained 5 nM ScCTS1, 0.1 mg/ml BSA, and 25–800 mM fluorogenic
substrate in McIlvaine’s buffer (100 mM citric acid, 200 mM sodium
phosphate [pH 5.5]) to a final volume of 50 ml. Reaction mixtures
were incubated for 30 min at 37C, after which the reaction was
stopped with the addition of 25 ml of 3 M glycine-NaOH (pH 10.3).
The fluorescence of the released 4-methylumbelliferone was quanti-
fied using an Flx 800 microtiterplate fluorescence reader (Bio-Tek In-
struments Inc) (excitation 360 nm, emission 460 nm). The standard
used was 4-methylumbelliferone at a concentration range covering
those of the substrate used in the kinetic experiments. Experiments
were performed in triplicate. Production of 4-methylumbelliferone
was linear with time for the incubation period used, and less than
10% of available substrate was hydrolyzed. The pH study was carried
out with a mix of citric acid and sodium phosphate (McIlvaine’s buffer
system, pH from 2.2 to 7), and the assay was done under the same
conditions as described above. The backgrounds were determined
with all the components of the assay and at each individual concentra-
tion of the substrate without the enzyme. The backgrounds ranged
from 1,100 to 1,600 fluorescence units and were used to correct the
values obtained when the enzyme was present (fluorescence units
up to 45,000). The stability of the enzyme at different pHs and concen-
trations of substrates was also verified. The enzyme behaved with
a very similar activity (from pH 2.2 to 5) during a time-course incubation
(up to 25 hr), showing that the pH did not affect the stability of the en-
zyme. To check for linearity of the enzyme at different pH, a continuous
assay was established (same conditions but without stopping the re-
action) at pH 2.2, 2.6, 3.0, 4.0, 5.0, 6.0, and 7.0, and the reaction fol-
lowed for up to 5 hr. From these experiments, appropriate reaction
times were selected for the stopped, steady-state kinetics assays,
such that the reactions did not consume more than 10% of available
substrate.
The same assay was used for screening The Prestwick Chemical
Library (a library of 880 drug-like molecules obtained from Prestwick
Chemical, Inc.). The inhibitors were screened at 40 mg/ml (approxi-
mately equivalent to 80 mM, assuming a molecular weight of 500) using
a 4MU-GlcNAc3 (substrate) concentration of 100 mM.
The IC50s of allosamidin, kinetin, acetazolamide, and 8-chlorotheo-
phylline were determined using the same protocol but with a constant
substrate concentration of 100 mM, 0.1–50 mM allosamidin, 1–500 mM
kinetin or acetazolamide, and 0.1–6 mM 8-chlorotheophylline. In order
to check for potential irreversibility or tight binding character of kinetin,
a continuous assay was followed for 5 hr, revealing that the activity
was linear in absence or presence of 50 or 100 mM kinetin. Linewea-
ver-Burk analyses of steady-state kinetics with 50–500 mM of sub-
strate in the presence of different concentrations of kinetin/acetazol-
amide were used to show that these molecules were competitive
inhibitors.
Crystallization and Structure Determination
The protein was spin-concentrated up to 11.5 mg/ml. Crystals were
grown by sitting drop experiments at 20C by mixing 1 ml of protein
with an equal volume of a reservoir solution (0.1 M HEPES, 0.8 M
monosodium di-hydrogen phosphate, and 0.8 M monopotassium
dihydrogen phosphate [pH 7.5]). The crystals under these conditions
appeared within 5–9 days. For flash cooling, 0.1 M HEPES and 30%
glycerol (pH 7.5) was used for native crystals prior to data collection.
For the ScCTS1-inhibitor complexes, native crystals were soaked
with either 8-chlorotheophylline (30 mM), acetazolamide (30 mM), or
kinetin (saturated solution) for more than 30 min. These crystals were
soaked with 0.1 M HEPES, 40% PEG 600 (pH 7.5) for 10 s and flash
cooled with liquid nitrogen for storage and transfer to the synchrotron.
Data were collected at the European Synchrotron Radiation Facility89–599, May 2007 ª2007 Elsevier Ltd All rights reserved 597
Chemistry & Biology
Structure of Saccharomyces cerevisiae Chitinase 1(Grenoble, France). Diffraction data were processed with the HKL suite
[35] (Table 1).
The native ScCTS1 structure was solved by molecular replacement
with MOLREP [36] using hevamine (PDB code 2HVM [3]) as a search
model, giving a single solution with one molecule in the asymmetric
unit. The resulting electron density map was of very good quality, al-
lowing ARP/WARP to automatically build 270 out of 294 residues of
the polypeptide chain. Further refinement (with REFMAC5 [37]) and
model building (with COOT [38]) yielded a model with the final statistics
shown in Table 1.
Refinement of ScCTS1 complexed with 8-chlorotheophylline, kine-
tin and acetazolamide was initiated by rigid-body refinement, followed
by simulated annealing with CNS [39] (for 8-chlorotheophylline) and it-
erative cycles of refinement and model building. Models for ligands
were not included until their conformations were completely defined
by unbiased jFoj  jFcj, fcalc electron density maps (Figures 4 and 5).
Ligand starting structures and topologies were generated with
PRODRG [40]. Further refinement resulted in the final models
described in Table 1. WHAT IF [41] was used to calculate hydrogen
bonds, and PyMol [42] was used to generate pictures.
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